Walsh Colin 4
4 · Elevation Oncology, Inc. · Filed Jun 28, 2021
Insider Transaction Report
Form 4
Walsh Colin
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2021-06-24+31,238→ 31,238 totalExercise: $16.00Exp: 2031-06-23→ Common Stock (31,238 underlying)
Footnotes (1)
- [F1]The stock option vests as of 1/36 of the total shares monthly beginning on July 24, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.